Announcements
Our Webinar Series – Register Your Interest
Our webinars are free, interactive, and designed to empower everyone affected by FL. Register today and stay informed on these important discussions.
Upcoming Webinars
Our webinars are designed to be an educational and engaging way of answering the most frequently asked questions and providing up-to-date information on follicular lymphoma. Stay tuned for more webinars in the coming months and join our mailing list to be updated as they’re added.
For the best attendee experience, please read our Zoom Webinar Guidelines
Our webinars are free, interactive, and designed to empower everyone affected by FL. Register today and stay informed on these important discussions.
We hope you enjoy watching our previous webinars. If you’d like to give feedback or suggestions for future webinars, or if you have any specific questions, then please contact us at info@theflf.org.
Join us for a practical and empowering discussion about current treatment options for follicular lymphoma (FL). Whether you’re newly diagnosed or considering your next steps, this session will help you better understand potential options and how to navigate the decision-making process.
In this informative webinar, expert clinicians and individuals living with FL came together to explore how to recognise the signs of progression, available treatment options, and what to expect.
Watch our recent webinar with a panel of inspiring individuals and expert speakers as they share uplifting personal stories, professional advice and the unique perspective of supporting a loved one with FL.
This session brings together leading experts and a patient who has experienced CAR-T therapy to provide a comprehensive look at emerging therapies for FL, including CAR-T, bispecific antibodies, BTK inhibitors, and more.
This inspiring session on Relapsed FL, which took place on September 26th 2024, provided the audience with valuable expert discussion and a patient perspective.
View our webinar focused on sharing experiences and improving understanding of clinical trials.
